image
Healthcare - Medical - Instruments & Supplies - NYSE - US
$ 192.15
0.898 %
$ 8.92 B
Market Cap
38.74
P/E
1. INTRINSIC VALUE

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.[ Read More ]

The intrinsic value of one TFX stock under the base case scenario is HIDDEN Compared to the current market price of 192 USD, Teleflex Incorporated is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart TFX

image
FINANCIALS
2.97 B REVENUE
6.57%
506 M OPERATING INCOME
1.32%
356 M NET INCOME
-1.88%
511 M OPERATING CASH FLOW
49.25%
-621 M INVESTING CASH FLOW
-140.84%
38.5 M FINANCING CASH FLOW
117.72%
764 M REVENUE
1.96%
149 M OPERATING INCOME
18.38%
110 M NET INCOME
37.75%
233 M OPERATING CASH FLOW
155.53%
-21.2 M INVESTING CASH FLOW
29.78%
-175 M FINANCING CASH FLOW
-209.17%
Balance Sheet Decomposition Teleflex Incorporated
image
Current Assets 1.41 B
Cash & Short-Term Investments 223 M
Receivables 443 M
Other Current Assets 741 M
Non-Current Assets 6.13 B
Long-Term Investments 0
PP&E 603 M
Other Non-Current Assets 5.52 B
Current Liabilities 607 M
Accounts Payable 132 M
Short-Term Debt 87.5 M
Other Current Liabilities 387 M
Non-Current Liabilities 2.48 B
Long-Term Debt 1.84 B
Other Non-Current Liabilities 646 M
EFFICIENCY
Earnings Waterfall Teleflex Incorporated
image
Revenue 2.97 B
Cost Of Revenue 1.33 B
Gross Profit 1.65 B
Operating Expenses 1.08 B
Operating Income 506 M
Other Expenses 150 M
Net Income 356 M
RATIOS
55.37% GROSS MARGIN
55.37%
17.02% OPERATING MARGIN
17.02%
11.98% NET MARGIN
11.98%
8.02% ROE
8.02%
4.73% ROA
4.73%
6.67% ROIC
6.67%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Teleflex Incorporated
image
Net Income 356 M
Depreciation & Amortization 242 M
Capital Expenditures -91.4 M
Stock-Based Compensation 31.5 M
Change in Working Capital -112 M
Others -18.1 M
Free Cash Flow 419 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Teleflex Incorporated
image
Wall Street analysts predict an average 1-year price target for TFX of $249 , with forecasts ranging from a low of $235 to a high of $275 .
TFX Lowest Price Target Wall Street Target
235 USD 22.30%
TFX Average Price Target Wall Street Target
249 USD 29.78%
TFX Highest Price Target Wall Street Target
275 USD 43.12%
4. DIVIDEND ANALYSIS
0.14% DIVIDEND YIELD
0.34 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Teleflex Incorporated
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
639 K USD 1
6-9 MONTHS
1.67 M USD 1
9-12 MONTHS
9.68 M USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
3 months ago
Aug 16, 2024
Sell 639 K USD
RANDLE STUART A
Director
- 2674
238.93 USD
8 months ago
Mar 05, 2024
Sell 1.67 M USD
Hicks Cameron P
Corp. VP & Chief HR Officer
- 7401
225 USD
10 months ago
Dec 27, 2023
Sell 5.9 M USD
Kelly Liam
Chairman, President & CEO
- 23585
250.124 USD
10 months ago
Dec 27, 2023
Sell 671 K USD
Kelly Liam
Chairman, President & CEO
- 2671
251.16 USD
11 months ago
Nov 29, 2023
Sell 413 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 1866
221.5 USD
11 months ago
Nov 29, 2023
Sell 1.03 M USD
POWELL THOMAS E
Executive Vice President & CFO
- 4629
222.41 USD
11 months ago
Nov 29, 2023
Sell 1.29 M USD
POWELL THOMAS E
Executive Vice President & CFO
- 5796
223.35 USD
11 months ago
Nov 29, 2023
Sell 372 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 1661
224.13 USD
1 year ago
May 10, 2023
Sell 742 K USD
RANDLE STUART A
Director
- 3021
245.71 USD
1 year ago
Dec 30, 2022
Sell 4.09 M USD
Kelly Liam
Chairman, President & CEO
- 16340
250.03 USD
1 year ago
Dec 30, 2022
Sell 753 USD
Kelly Liam
Chairman, President & CEO
- 3
251 USD
2 years ago
Jun 07, 2022
Sell 854 K USD
RANDLE STUART A
director:
- 3014
283.31 USD
2 years ago
Dec 27, 2021
Sell 2.97 M USD
Kelly Liam
Chairman, President & CEO
- 8987
330 USD
2 years ago
Nov 30, 2021
Bought 154 K USD
Krakauer Andrew A
Director
+ 500
307.4643 USD
2 years ago
Nov 30, 2021
Bought 154 K USD
Krakauer Andrew A
Director
+ 500
307 USD
3 years ago
Nov 10, 2021
Sell 1.26 M USD
Hicks Cameron P
Corp. VP & Chief HR Officer
- 3600
350 USD
3 years ago
Aug 18, 2021
Sell 377 K USD
Kelly Liam
Chairman, President & CEO
- 1007
374.85 USD
3 years ago
Aug 18, 2021
Sell 1.52 M USD
Kelly Liam
Chairman, President & CEO
- 4045
375.32 USD
3 years ago
Aug 18, 2021
Sell 396 K USD
Kelly Liam
Chairman, President & CEO
- 1051
376.43 USD
3 years ago
Aug 18, 2021
Sell 571 K USD
Kelly Liam
Chairman, President & CEO
- 1513
377.53 USD
3 years ago
Aug 18, 2021
Sell 519 K USD
Kelly Liam
Chairman, President & CEO
- 1371
378.92 USD
3 years ago
Jul 12, 2021
Sell 934 K USD
Klasko Stephen K. M.D.
Director
- 2214
422 USD
3 years ago
Jul 12, 2021
Sell 508 K USD
Klasko Stephen K. M.D.
Director
- 1200
423.39 USD
3 years ago
Jul 12, 2021
Sell 63.6 K USD
Klasko Stephen K. M.D.
Director
- 150
423.95 USD
3 years ago
Jun 10, 2021
Sell 660 K USD
Hicks Cameron P
Corp. VP & Chief HR Officer
- 1671
395.05 USD
3 years ago
Jun 10, 2021
Sell 478 K USD
Hicks Cameron P
Corp. VP & Chief HR Officer
- 1205
396.3 USD
3 years ago
Jun 10, 2021
Sell 238 K USD
Hicks Cameron P
Corp. VP & Chief HR Officer
- 600
397.21 USD
3 years ago
Jun 04, 2021
Sell 943 K USD
RANDLE STUART A
Director
- 2384
395.66 USD
3 years ago
Mar 15, 2021
Sell 841 K USD
Hicks Cameron P
Corp. VP & Chief HR Officer
- 2000
420.61 USD
3 years ago
Mar 15, 2021
Sell 339 K USD
Hicks Cameron P
Corp. VP & Chief HR Officer
- 803
421.66 USD
3 years ago
Mar 15, 2021
Sell 83.2 K USD
Hicks Cameron P
Corp. VP & Chief HR Officer
- 197
422.47 USD
3 years ago
Nov 30, 2020
Sell 1.11 M USD
Hicks Cameron P
Corp. VP, HR & Communications
- 2985
371 USD
4 years ago
Oct 26, 2020
Sell 72.3 K USD
Klasko Stephen K. M.D.
Director
- 200
361.38 USD
4 years ago
Sep 25, 2020
Sell 65.2 K USD
Klasko Stephen K. M.D.
Director
- 200
326.15 USD
4 years ago
Aug 25, 2020
Sell 74.7 K USD
Klasko Stephen K. M.D.
Director
- 200
373.74 USD
4 years ago
Jul 27, 2020
Sell 77.3 K USD
Klasko Stephen K. M.D.
Director
- 200
386.35 USD
4 years ago
May 26, 2020
Sell 75 K USD
Klasko Stephen K. M.D.
Director
- 200
375.14 USD
4 years ago
May 07, 2020
Sell 481 K USD
Hicks Cameron P
Corp. VP, HR & Communications
- 1400
343.57 USD
4 years ago
May 05, 2020
Sell 273 K USD
Deren John
VP & Chief Accounting Officer
- 826
330.2365 USD
4 years ago
May 05, 2020
Sell 88 K USD
Deren John
VP & Chief Accounting Officer
- 267
329.6688 USD
4 years ago
Apr 27, 2020
Sell 68.5 K USD
Klasko Stephen K. M.D.
Director
- 200
342.26 USD
4 years ago
Mar 25, 2020
Sell 51 K USD
Klasko Stephen K. M.D.
Director
- 200
254.75 USD
4 years ago
Feb 28, 2020
Sell 756 K USD
Deren John
VP & Chief Accounting Officer
- 2184
346.17 USD
4 years ago
Feb 27, 2020
Sell 138 K USD
Leyden James J
VP, General Counsel, Secretary
- 400
344.26 USD
4 years ago
Feb 27, 2020
Sell 121 K USD
Leyden James J
VP, General Counsel, Secretary
- 350
344.2943 USD
4 years ago
Feb 25, 2020
Sell 72.2 K USD
Klasko Stephen K. M.D.
Director
- 200
360.95 USD
4 years ago
Jan 27, 2020
Sell 75.1 K USD
Klasko Stephen K. M.D.
Director
- 200
375.71 USD
4 years ago
Dec 26, 2019
Sell 74.9 K USD
Klasko Stephen K. M.D.
Director
- 200
374.35 USD
4 years ago
Nov 26, 2019
Sell 455 K USD
Hicks Cameron P
Vice President, Global HR
- 1300
350 USD
4 years ago
Nov 26, 2019
Sell 347 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 1000
347.31 USD
4 years ago
Nov 26, 2019
Sell 1.4 M USD
POWELL THOMAS E
Executive Vice President & CFO
- 4000
349.05 USD
4 years ago
Nov 25, 2019
Sell 69.3 K USD
Klasko Stephen K. M.D.
Director
- 200
346.63 USD
5 years ago
Nov 12, 2019
Sell 113 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 345
328.03 USD
5 years ago
Nov 12, 2019
Sell 616 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 1868
329.87 USD
5 years ago
Nov 12, 2019
Sell 1.75 M USD
POWELL THOMAS E
Executive Vice President & CFO
- 5287
331.11 USD
5 years ago
Nov 04, 2019
Sell 481 K USD
SMITH BENSON
Director
- 1400
343.66 USD
5 years ago
Nov 04, 2019
Sell 830 K USD
SMITH BENSON
Director
- 2405
345.03 USD
5 years ago
Nov 04, 2019
Sell 1.44 M USD
SMITH BENSON
Director
- 4163
345.89 USD
5 years ago
Nov 04, 2019
Sell 39.2 K USD
SMITH BENSON
Director
- 113
346.5 USD
5 years ago
Nov 04, 2019
Sell 139 K USD
SMITH BENSON
Director
- 400
347.76 USD
5 years ago
Oct 31, 2019
Sell 5.63 M USD
SMITH BENSON
Director
- 16573
340 USD
5 years ago
Oct 31, 2019
Sell 145 K USD
SMITH BENSON
Director
- 427
340.275 USD
5 years ago
Oct 29, 2019
Sell 151 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 465
325.36 USD
5 years ago
Oct 29, 2019
Sell 1.05 M USD
POWELL THOMAS E
Executive Vice President & CFO
- 3216
326.96 USD
5 years ago
Oct 29, 2019
Sell 1.25 M USD
POWELL THOMAS E
Executive Vice President & CFO
- 3819
328.05 USD
5 years ago
Oct 25, 2019
Sell 63.2 K USD
Klasko Stephen K. M.D.
Director
- 200
316.0073 USD
5 years ago
Oct 15, 2019
Sell 65 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 200
324.78 USD
5 years ago
Oct 15, 2019
Sell 248 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 759
326.81 USD
5 years ago
Oct 15, 2019
Sell 344 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 1051
327.77 USD
5 years ago
Oct 15, 2019
Sell 1.81 M USD
POWELL THOMAS E
Executive Vice President & CFO
- 5490
328.93 USD
5 years ago
Oct 01, 2019
Sell 26.4 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 79
333.57 USD
5 years ago
Oct 01, 2019
Sell 210 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 627
335.41 USD
5 years ago
Oct 01, 2019
Sell 424 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 1260
336.35 USD
5 years ago
Oct 01, 2019
Sell 518 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 1534
337.5 USD
5 years ago
Oct 01, 2019
Sell 440 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 1300
338.73 USD
5 years ago
Oct 01, 2019
Sell 917 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 2700
339.73 USD
5 years ago
Sep 25, 2019
Sell 68.5 K USD
Klasko Stephen K. M.D.
Director
- 200
342.5 USD
5 years ago
Sep 23, 2019
Sell 2.89 M USD
SMITH BENSON
Director
- 8500
340 USD
5 years ago
Sep 17, 2019
Sell 495 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 1500
330 USD
5 years ago
Sep 17, 2019
Sell 184 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 554
332.11 USD
5 years ago
Sep 17, 2019
Sell 444 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 1332
333.11 USD
5 years ago
Sep 17, 2019
Sell 1.37 M USD
POWELL THOMAS E
Executive Vice President & CFO
- 4114
334 USD
5 years ago
Sep 06, 2019
Sell 2.17 M USD
POWELL THOMAS E
Executive Vice President & CFO
- 6119
355.32 USD
5 years ago
Sep 06, 2019
Sell 456 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 1281
356.36 USD
5 years ago
Sep 06, 2019
Sell 35.7 K USD
POWELL THOMAS E
Executive Vice President & CFO
- 100
357.27 USD
5 years ago
Aug 26, 2019
Sell 72.2 K USD
Klasko Stephen K. M.D.
Director
- 200
361.06 USD
5 years ago
Aug 15, 2019
Sell 370 K USD
Hicks Cameron P
Vice President, Global HR
- 1000
370 USD
5 years ago
Aug 14, 2019
Sell 584 K USD
Deren John
VP & Chief Accounting Officer
- 1601
364.9477 USD
5 years ago
Aug 14, 2019
Sell 147 K USD
Deren John
VP & Chief Accounting Officer
- 403
365.5304 USD
5 years ago
Jul 25, 2019
Sell 68.7 K USD
Klasko Stephen K. M.D.
Director
- 200
343.28 USD
5 years ago
Jul 17, 2019
Sell 631 K USD
SMITH BENSON
Director
- 1900
332.06 USD
5 years ago
Jul 17, 2019
Sell 2.2 M USD
SMITH BENSON
Director
- 6600
332.82 USD
5 years ago
Jul 03, 2019
Sell 729 K USD
SMITH BENSON
Director
- 2200
331.43 USD
5 years ago
Jul 03, 2019
Sell 2.06 M USD
SMITH BENSON
Director
- 6200
332.06 USD
5 years ago
Jul 03, 2019
Sell 33.3 K USD
SMITH BENSON
Director
- 100
332.72 USD
5 years ago
Jun 25, 2019
Sell 66.4 K USD
Klasko Stephen K. M.D.
Director
- 200
332.17 USD
5 years ago
Jun 20, 2019
Sell 383 K USD
Boylan Karen
VP, Global Strategic Projects
- 1149
333.215 USD
5 years ago
Jun 18, 2019
Sell 892 K USD
RANDLE STUART A
Director
- 2700
330.317 USD
5 years ago
Jun 18, 2019
Sell 99.1 K USD
RANDLE STUART A
Director
- 300
330.385 USD
5 years ago
Jun 18, 2019
Sell 231 K USD
Hicks Cameron P
Vice President, Global HR
- 700
330.7 USD
5 years ago
Jun 19, 2019
Sell 593 K USD
SMITH BENSON
Director
- 1800
329.41 USD
5 years ago
Jun 19, 2019
Sell 1.24 M USD
SMITH BENSON
Director
- 3741
330.47 USD
5 years ago
Jun 19, 2019
Sell 236 K USD
SMITH BENSON
Director
- 712
331.37 USD
5 years ago
Jun 19, 2019
Sell 746 K USD
SMITH BENSON
Director
- 2247
332.09 USD
5 years ago
Jun 05, 2019
Sell 88.1 K USD
SMITH BENSON
Director
- 300
293.59 USD
5 years ago
Jun 05, 2019
Sell 867 K USD
SMITH BENSON
Director
- 2937
295.2 USD
5 years ago
Jun 05, 2019
Sell 726 K USD
SMITH BENSON
Director
- 2453
296.12 USD
5 years ago
Jun 05, 2019
Sell 835 K USD
SMITH BENSON
Director
- 2810
296.99 USD
5 years ago
May 28, 2019
Sell 59.2 K USD
Klasko Stephen K. M.D.
Director
- 200
295.81 USD
5 years ago
May 22, 2019
Sell 699 K USD
SMITH BENSON
Director
- 2380
293.65 USD
5 years ago
May 22, 2019
Sell 1.54 M USD
SMITH BENSON
Director
- 5230
294.79 USD
5 years ago
May 22, 2019
Sell 263 K USD
SMITH BENSON
Director
- 890
295.68 USD
5 years ago
May 09, 2019
Sell 447 K USD
Hicks Cameron P
Vice President, Global HR
- 1500
298.1445 USD
5 years ago
May 08, 2019
Sell 381 K USD
SMITH BENSON
Director
- 1300
292.89 USD
5 years ago
May 08, 2019
Sell 315 K USD
SMITH BENSON
Director
- 1070
294.03 USD
5 years ago
May 08, 2019
Sell 1.81 M USD
SMITH BENSON
Director
- 6130
294.95 USD
5 years ago
Apr 24, 2019
Sell 248 K USD
SMITH BENSON
Director
- 900
275.9 USD
5 years ago
Apr 24, 2019
Sell 387 K USD
SMITH BENSON
Director
- 1400
276.45 USD
5 years ago
Apr 24, 2019
Sell 333 K USD
SMITH BENSON
Director
- 1200
277.56 USD
5 years ago
Apr 24, 2019
Sell 1.23 M USD
SMITH BENSON
Director
- 4400
278.93 USD
5 years ago
Apr 24, 2019
Sell 156 K USD
SMITH BENSON
Director
- 560
279.22 USD
5 years ago
Apr 25, 2019
Sell 55.4 K USD
Klasko Stephen K. M.D.
Director
- 200
277.14 USD
5 years ago
Apr 10, 2019
Sell 151 K USD
SMITH BENSON
Director
- 500
302.8 USD
5 years ago
Apr 10, 2019
Sell 212 K USD
SMITH BENSON
Director
- 698
303.92 USD
5 years ago
Apr 10, 2019
Sell 367 K USD
SMITH BENSON
Director
- 1202
305.18 USD
5 years ago
Apr 10, 2019
Sell 1.16 M USD
SMITH BENSON
Director
- 3800
306.2 USD
5 years ago
Apr 10, 2019
Sell 706 K USD
SMITH BENSON
Director
- 2300
306.79 USD
5 years ago
Mar 28, 2019
Sell 60.3 K USD
Klasko Stephen K. M.D.
Director
- 200
301.68 USD
5 years ago
Mar 28, 2019
Sell 329 K USD
SMITH BENSON
Director
- 1100
298.64 USD
5 years ago
Mar 28, 2019
Sell 900 K USD
SMITH BENSON
Director
- 3000
299.85 USD
5 years ago
Mar 28, 2019
Sell 1.05 M USD
SMITH BENSON
Director
- 3500
300.54 USD
5 years ago
Mar 28, 2019
Sell 271 K USD
SMITH BENSON
Director
- 900
301.44 USD
5 years ago
Mar 11, 2019
Sell 36.3 K USD
Deren John
VP & Chief Accounting Officer
- 125
290.4272 USD
5 years ago
Mar 11, 2019
Sell 895 K USD
RANDLE STUART A
Director
- 3082
290.3656 USD
5 years ago
Mar 11, 2019
Sell 267 K USD
RANDLE STUART A
Director
- 918
291.0339 USD
7. News
Teleflex to Present at the Jefferies London Healthcare Conference WAYNE, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Jefferies London Healthcare Conference, on Thursday, November 21, 2024, at 9:30 a.m. (GMT). globenewswire.com - 1 week ago
Here's Why Teleflex (TFX) is a Strong Growth Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 1 week ago
Why Teleflex (TFX) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 2 weeks ago
Teleflex Q3 Earnings Top, Stock Falls on Lowered 2024 Revenue Outlook TFX benefits from a diversified product portfolio in the third quarter of 2024, with strength in the Vascular Access and Interventional segments. zacks.com - 2 weeks ago
Teleflex Incorporated (TFX) Q3 2024 Earnings Call Transcript Teleflex Incorporated (NYSE:TFX ) Q3 2024 Results Conference Call October 31, 2024 8:00 AM ET Company Participants Lawrence Keusch - Vice President-Investor Relations & Strategy Development Liam Kelly - Chairman, President & Chief Executive Officer Thomas Powell - Executive Vice President & Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Shagun Singh - RBC Matt Taylor - Jefferies Larry Biegelsen - Wells Fargo Anthony Petrone - Mizuho Group David Turkaly - Citizens JMP Craig Bijou - Bank of America Michael Polark - Wolfe Research Mike Matson - Needham Kristen Stewart - CL King Operator Good morning, ladies and gentlemen, and welcome to the Teleflex Third Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note that this conference call is being recorded, and will be available on the company's website for replay shortly. seekingalpha.com - 2 weeks ago
Teleflex (TFX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2 weeks ago
Teleflex (TFX) Surpasses Q3 Earnings Estimates Teleflex (TFX) came out with quarterly earnings of $3.49 per share, beating the Zacks Consensus Estimate of $3.38 per share. This compares to earnings of $3.64 per share a year ago. zacks.com - 2 weeks ago
Teleflex beats quarterly profit estimates on robust medical devices demand Surgical equipment maker Teleflex reported a better-than-expected profit for the third quarter on Thursday, helped by strong demand for its medical devices. reuters.com - 2 weeks ago
Teleflex Announces Quarterly Dividend WAYNE, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 16, 2024, to shareholders of record at the close of business on November 15, 2024. globenewswire.com - 2 weeks ago
Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook WAYNE, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 29, 2024. globenewswire.com - 2 weeks ago
First Patient Enrolled in Teleflex's Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT) Randomized, controlled study will be first in personalized spacing evidence to include patients who have a prostate cancer recurrence after prostatectomy. Randomized, controlled study will be first in personalized spacing evidence to include patients who have a prostate cancer recurrence after prostatectomy. globenewswire.com - 2 weeks ago
TFX Stock to Gain From Launch of New Vascular Access Devices in Canada Teleflex launches the next-generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet in Canada. zacks.com - 2 weeks ago
8. Profile Summary

Teleflex Incorporated TFX

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 8.92 B
Dividend Yield 0.14%
Description Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Contact 550 East Swedesford Road, Wayne, PA, 19087-1603 https://www.teleflex.com
IPO Date March 17, 1980
Employees 14500
Officers Mr. John R. Deren Corporate Vice President & Chief Accounting Officer Mr. Timothy F. Duffy Vice President & Chief Information Officer Mr. Jay White Corporate Vice President & President of Global Commercial Mr. Cameron P. Hicks Corporate Vice President & Chief Human Resources Officer Mr. Matthew James President, EMEA & Global Urology Ms. Michelle Fox Corporate Vice President & Chief Medical Officer Mr. James Ferguson President & GM of Surgical Mr. Liam J. Kelly Chairman, President & Chief Executive Officer Mr. Thomas E. Powell BS, MBA Executive Vice President & Chief Financial Officer Mr. Howard Cyr Corporate Vice President & Chief Compliance Officer